Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2009

01.04.2009 | Article

Comparison of three chromogenic media and enrichment broth media for the detection of methicillin-resistant Staphylococcus aureus from mucocutaneous screening specimens

Comparison of MRSA chromogenic media

verfasst von: C. Nonhoff, O. Denis, A. Brenner, P. Buidin, N. Legros, C. Thiroux, M. Dramaix, M. J. Struelens

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

This study compares the performance of three chromogenic culture agar plates, chromID MRSA, MRSA-Screen and MRSA-Select, by challenging with a collection of Staphylococcus aureus strains and screening samples obtained from hospitalised patients. All chromogenic media showed excellent sensitivity (>95%) and specificity after 18 h on the methicillin-resistant Staphylococcus aureus (MRSA) collection strains, but the specificity of MRSA-Screen decreased markedly after 42 h. Sixty-eight of 1,002 screening specimens yielded MRSA on at least one medium. The sensitivity of all media to detecting MRSA after 18 h was <50%, but this increased to 75% (chromID MRSA), 81% (MRSA-Screen) and 72% (MRSA-Select) after 42 h and 85% after enrichment and plating on the same media. The specificity at 18 h was excellent, but was significantly lower for MRSA-Screen after 42 h and enrichment. In conclusion, all media showed equivalent sensitivities after 18 h of incubation and performed better when enriched before inoculation. MRSA-Screen was more sensitive but less specific than the two other media after 42 h of incubation.
Literatur
1.
Zurück zum Zitat Chambers HF (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10(4):781–791PubMed Chambers HF (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10(4):781–791PubMed
2.
Zurück zum Zitat Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9(8):978–984PubMed Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9(8):978–984PubMed
3.
Zurück zum Zitat Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG et al (2005) Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother 56(6):1103–1106 doi:10.1093/jac/dki379 PubMedCrossRef Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG et al (2005) Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother 56(6):1103–1106 doi:10.​1093/​jac/​dki379 PubMedCrossRef
4.
Zurück zum Zitat Karchmer TB, Durbin LJ, Simonton BM, Farr BM (2002) Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 51(2):126–132 doi:10.1053/jhin.2002.1200 PubMedCrossRef Karchmer TB, Durbin LJ, Simonton BM, Farr BM (2002) Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 51(2):126–132 doi:10.​1053/​jhin.​2002.​1200 PubMedCrossRef
5.
Zurück zum Zitat Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H et al (2006) Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 63(Suppl 1):S1–S44 doi:10.1016/j.jhin.2006.01.001 PubMedCrossRef Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H et al (2006) Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 63(Suppl 1):S1–S44 doi:10.​1016/​j.​jhin.​2006.​01.​001 PubMedCrossRef
6.
Zurück zum Zitat Brown DF, Edwards DI, Hawkey PM, Morrison D, Ridgway GL, Towner KJ et al (2005) Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56(6):1000–1018 doi:10.1093/jac/dki372 PubMedCrossRef Brown DF, Edwards DI, Hawkey PM, Morrison D, Ridgway GL, Towner KJ et al (2005) Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56(6):1000–1018 doi:10.​1093/​jac/​dki372 PubMedCrossRef
7.
Zurück zum Zitat Gorss EB (1992) Prospective, focused surveillance for oxacillin-resistant Staphylococcus aureus. In: Clinical microbiology procedures handbook. ASM Press, Washington, DC, pp 15.1–15.2 Gorss EB (1992) Prospective, focused surveillance for oxacillin-resistant Staphylococcus aureus. In: Clinical microbiology procedures handbook. ASM Press, Washington, DC, pp 15.1–15.2
8.
Zurück zum Zitat Le Groupement pour le Dépistage, l’Etude et la Prévention des Infections Hospitalières—Groep ter Opsporing, Studie en Preventie van de Infecties in de Ziekenhuizen (GDEPIH–GOSPIZ) (2003). Guidelines for control and prevention of methicillin-resistant Staphylococcus aureus transmission in Belgian hospitals. Available online at: http://www.belgianinfectioncontrolsociety.be Le Groupement pour le Dépistage, l’Etude et la Prévention des Infections Hospitalières—Groep ter Opsporing, Studie en Preventie van de Infecties in de Ziekenhuizen (GDEPIH–GOSPIZ) (2003). Guidelines for control and prevention of methicillin-resistant Staphylococcus aureus transmission in Belgian hospitals. Available online at: http://​www.​belgianinfection​controlsociety.​be
9.
Zurück zum Zitat Gaillot O, Wetsch M, Fortineau N, Berche P (2000) Evaluation of CHROMagar Staph. aureus, a new chromogenic medium, for isolation and presumptive identification of Staphylococcus aureus from human clinical specimens. J Clin Microbiol 38(4):1587–1591PubMed Gaillot O, Wetsch M, Fortineau N, Berche P (2000) Evaluation of CHROMagar Staph. aureus, a new chromogenic medium, for isolation and presumptive identification of Staphylococcus aureus from human clinical specimens. J Clin Microbiol 38(4):1587–1591PubMed
10.
Zurück zum Zitat Carricajo A, Treny A, Fonsale N, Bes M, Reverdy ME, Gille Y et al (2001) Performance of the chromogenic medium CHROMagar Staph Aureus and the Staphychrom coagulase test in the detection and identification of Staphylococcus aureus in clinical specimens. J Clin Microbiol 39(7):2581–2583 doi:10.1128/JCM.39.7.2581-2583.2001 PubMedCrossRef Carricajo A, Treny A, Fonsale N, Bes M, Reverdy ME, Gille Y et al (2001) Performance of the chromogenic medium CHROMagar Staph Aureus and the Staphychrom coagulase test in the detection and identification of Staphylococcus aureus in clinical specimens. J Clin Microbiol 39(7):2581–2583 doi:10.​1128/​JCM.​39.​7.​2581-2583.​2001 PubMedCrossRef
12.
Zurück zum Zitat Denis O, Deplano A, Nonhoff C, Hallin M, De Ryck R, Vanhoof R et al (2006) In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrob Agents Chemother 50(8):2680–2685 doi:10.1128/AAC.00272-06 PubMedCrossRef Denis O, Deplano A, Nonhoff C, Hallin M, De Ryck R, Vanhoof R et al (2006) In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrob Agents Chemother 50(8):2680–2685 doi:10.​1128/​AAC.​00272-06 PubMedCrossRef
13.
Zurück zum Zitat Hallin M, Denis O, Deplano A, De Mendonça R, De Ryck R, Rottiers S et al (2007) Genetic relatedness between methicillin-susceptible and methicillin-resistant Staphylococcus aureus: results of a national survey. J Antimicrob Chemother 59(3):465–472 doi:10.1093/jac/dkl535 PubMedCrossRef Hallin M, Denis O, Deplano A, De Mendonça R, De Ryck R, Rottiers S et al (2007) Genetic relatedness between methicillin-susceptible and methicillin-resistant Staphylococcus aureus: results of a national survey. J Antimicrob Chemother 59(3):465–472 doi:10.​1093/​jac/​dkl535 PubMedCrossRef
14.
Zurück zum Zitat Maes N, Magdalena J, Rottiers S, De Gheldre Y, Struelens MJ (2002) Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures. J Clin Microbiol 40(4):1514–1517 doi:10.1128/JCM.40.4.1514-1517.2002 PubMedCrossRef Maes N, Magdalena J, Rottiers S, De Gheldre Y, Struelens MJ (2002) Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures. J Clin Microbiol 40(4):1514–1517 doi:10.​1128/​JCM.​40.​4.​1514-1517.​2002 PubMedCrossRef
15.
Zurück zum Zitat Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Approved standard MS100-S17. CLSI (formerly NCCLS), Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Approved standard MS100-S17. CLSI (formerly NCCLS), Wayne, PA
16.
Zurück zum Zitat Roisin S, Nonhoff C, Denis O, Struelens MJ (2008) Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin. J Clin Microbiol 46(8):2525–2528 doi:10.1128/JCM.00291-08 PubMedCrossRef Roisin S, Nonhoff C, Denis O, Struelens MJ (2008) Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin. J Clin Microbiol 46(8):2525–2528 doi:10.​1128/​JCM.​00291-08 PubMedCrossRef
18.
Zurück zum Zitat Compernolle V, Verschraegen G, Claeys G (2007) Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 45(1):154–158 doi:10.1128/JCM.01115-06 PubMedCrossRef Compernolle V, Verschraegen G, Claeys G (2007) Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 45(1):154–158 doi:10.​1128/​JCM.​01115-06 PubMedCrossRef
19.
Zurück zum Zitat Flayhart D, Hindler JF, Bruckner DA, Hall G, Shrestha RK, Vogel SA et al (2005) Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol 43(11):5536–5540 doi:10.1128/JCM.43.11.5536-5540.2005 PubMedCrossRef Flayhart D, Hindler JF, Bruckner DA, Hall G, Shrestha RK, Vogel SA et al (2005) Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol 43(11):5536–5540 doi:10.​1128/​JCM.​43.​11.​5536-5540.​2005 PubMedCrossRef
20.
Zurück zum Zitat Louie L, Soares D, Meaney H, Vearncombe M, Simor AE (2006) Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44(12):4561–4563 doi:10.1128/JCM.01763-06 PubMedCrossRef Louie L, Soares D, Meaney H, Vearncombe M, Simor AE (2006) Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44(12):4561–4563 doi:10.​1128/​JCM.​01763-06 PubMedCrossRef
21.
23.
Zurück zum Zitat Stoakes L, Reyes R, Daniel J, Lennox G, John MA, Lannigan R et al (2006) Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44(2):637–639 doi:10.1128/JCM.44.2.637-639.2006 PubMedCrossRef Stoakes L, Reyes R, Daniel J, Lennox G, John MA, Lannigan R et al (2006) Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44(2):637–639 doi:10.​1128/​JCM.​44.​2.​637-639.​2006 PubMedCrossRef
24.
Zurück zum Zitat van Hal SJ, Stark D, Lockwood B, Marriott D, Harkness J (2007) Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol 45(8):2486–2490 doi:10.1128/JCM.00139-07 PubMedCrossRef van Hal SJ, Stark D, Lockwood B, Marriott D, Harkness J (2007) Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol 45(8):2486–2490 doi:10.​1128/​JCM.​00139-07 PubMedCrossRef
26.
Zurück zum Zitat Velasco D, del Mar Tomas M, Cartelle M, Beceiro A, Perez A, Molina F et al (2005) Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother 55(3):379–382 doi:10.1093/jac/dki017 PubMedCrossRef Velasco D, del Mar Tomas M, Cartelle M, Beceiro A, Perez A, Molina F et al (2005) Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother 55(3):379–382 doi:10.​1093/​jac/​dki017 PubMedCrossRef
27.
Zurück zum Zitat McKinney TK, Sharma VK, Craig WA, Archer GL (2001) Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and beta-lactamase regulators. J Bacteriol 183(23):6862–6868 doi:10.1128/JB.183.23.6862-6868.2001 PubMedCrossRef McKinney TK, Sharma VK, Craig WA, Archer GL (2001) Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and beta-lactamase regulators. J Bacteriol 183(23):6862–6868 doi:10.​1128/​JB.​183.​23.​6862-6868.​2001 PubMedCrossRef
28.
Zurück zum Zitat Felten A, Grandry B, Lagrange PH, Casin I (2002) Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol 40(8):2766–2771 doi:10.1128/JCM.40.8.2766-2771.2002 PubMedCrossRef Felten A, Grandry B, Lagrange PH, Casin I (2002) Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol 40(8):2766–2771 doi:10.​1128/​JCM.​40.​8.​2766-2771.​2002 PubMedCrossRef
29.
Zurück zum Zitat de San N, Denis O, Gasasira MF, De Mendonça R, Nonhoff C, Struelens MJ (2007) Controlled evaluation of the IDI-MRSA assay for detection of colonization by methicillin-resistant Staphylococcus aureus in diverse mucocutaneous specimens. J Clin Microbiol 45(4):1098–1101 doi:10.1128/JCM.02208-06 PubMedCrossRef de San N, Denis O, Gasasira MF, De Mendonça R, Nonhoff C, Struelens MJ (2007) Controlled evaluation of the IDI-MRSA assay for detection of colonization by methicillin-resistant Staphylococcus aureus in diverse mucocutaneous specimens. J Clin Microbiol 45(4):1098–1101 doi:10.​1128/​JCM.​02208-06 PubMedCrossRef
30.
Zurück zum Zitat Amsterdam D (1996) Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed) Antibiotics in laboratory medicine, 4th edn. Lippincott Williams & Wilkins, Baltimore, MD, pp 52–111 Amsterdam D (1996) Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed) Antibiotics in laboratory medicine, 4th edn. Lippincott Williams & Wilkins, Baltimore, MD, pp 52–111
31.
Metadaten
Titel
Comparison of three chromogenic media and enrichment broth media for the detection of methicillin-resistant Staphylococcus aureus from mucocutaneous screening specimens
Comparison of MRSA chromogenic media
verfasst von
C. Nonhoff
O. Denis
A. Brenner
P. Buidin
N. Legros
C. Thiroux
M. Dramaix
M. J. Struelens
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2009
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0637-9

Weitere Artikel der Ausgabe 4/2009

European Journal of Clinical Microbiology & Infectious Diseases 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.